79328756

Information

  • Trademark
  • 79328756
  • Serial Number
    79328756
  • Registration Number
    6993844
  • Filing Date
    September 30, 2021
    3 years ago
  • Registration Date
    March 07, 2023
    a year ago
  • Transaction Date
    November 04, 2023
    a year ago
  • Status Date
    March 07, 2023
    a year ago
  • Published for Opposition Date
    December 20, 2022
    2 years ago
  • Location Date
    March 07, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    JONES, JACQUELYN ANDRE
  • Attorney Docket Number
    191159.00011
    Attorney Name
    Michael J. Leonard
    Law Office Assigned Location Code
    N20
  • Owners
Mark Drawing Code
2000
Case File Statements
  • DM0000: The mark consists of a stylized five pointed blue star with a green heart in the center of the star and a curved blue line diagonally across the heart. The blue line has three blue bars sticking out of the bottom of the line and three blue bars sticking out of the top of the line. All instances of the color white represent background and/or transparent areas and are not part of the mark.
  • GS0091: Scientific apparatus, instruments and devices, namely, conductivity meters and ultra-high vacuum chambers for research and diagnostic purposes; downloadable software, for data analysis; downloadable software for the analysis of bioinformatic data, sequence data on fragmented sequence information, for pcr analysis and for next generation sequencing; chromatography columns for scientific or laboratory use; all the aforesaid goods for industrial and scientific purposes, in particular for molecular biological purposes for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment or for the purification of these molecules, and for reagent kits for industrial and scientific purposes, in particular for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment or purification of these molecules; laboratory equipment, in particular automated microfluidic and macrofluidic devices for the isolation, preparation, marking, replication or screening of genetic material or RNA or proteins
  • GS0051: Veterinary products, namely, veterinary diagnostic reagents; pharmaceutical preparations, namely, nucleic acid molecules for medical and veterinary purposes, for use in determining genotypes, profiling biopolymer, detecting disease, determining disease progression, and determining responses to drugs; diagnostic reagents for medical use in diagnosing inflammation, infection, central nervous system diseases, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, and cancer, comprised of reagents, processing chemicals and nucleic acid molecules; medical diagnostic test kits composed of medical diagnostic reagents for the detection of pathogens in the environment; clinical medical reagents and diagnostic reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic test kits composed of medical diagnostic reagents to identify, quantify and analyze dna or rna; reagents and enzymes for performing dna or rna analyzes for medical purposes
  • CC0000: The color(s) blue and green is/are claimed as a feature of the mark.
  • GS0011: Chemical, biochemical and biotechnological products, namely, chemical test kits for DNA and RNA isolation and rRNA depletion kits containing buffers and reagents for use in industry and science; Chemical reagents other than for medical or veterinary purposes for purifying and analyzing samples for use in the fields of molecular biology, chemistry, biochemistry, drug discovery, pharmacology, toxicology, molecular pathology, disease research, genomics and proteomics; chemical, biochemical and biotechnological substances for industrial and scientific purposes, namely, polypeptides and proteins for use in connection with molecular biological applications for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment; chemical, biochemical and biotechnological preparations for diagnostic and scientific purposes, laboratory reagents for scientific use and diagnostic reagents for clinical or medical laboratory use, all the aforesaid goods, in particular for the treatment and purification of samples of human, animal and plant cells and tissues and samples of microorganisms and of extracts therefrom and not for medical or veterinary purposes; diagnostic reagents for in vitro use in clinical chemistry; enzymes for scientific and research purposes, not for medical or veterinary purposes, in particular for use in kits and for use in carrying out DNA labeling, DNA replication, DNA analysis or RNA labeling, RNA replication, RNA analysis and for enzyme preparation
  • GS0421: Services in connection with scientific research and development, namely, scientific research consulting and scientific study in the field of research, development and diagnostics, and engineering, computer software, graphic design services in this field; scientific and technological services, namely, scientific analysis in the field of research, development and diagnostics relating to genomics, transcriptomics, proteomics and genetic engineering; design of pharmaceutical and medical diagnostic products and biochemical and biotechnological preparations relating to genomics, transcriptomics, proteomics and genetic engineering; scientific and technological services, namely, scientific research, development, diagnostics and analysis in the field of diagnostic chemicals and reagents, sorting of nucleotides, separation processes and purification processes, chemical screening analyzes and conducting diagnostic, forensic and genetic-medical tests for others; scientific research and development for others in the field of diagnostic chemical agents and reagents for use as diagnostic, therapeutic preparations and chemical screening and diagnostics for others; conducting quality control tests and quality control of scientific analyzes for others relating to nucleic acids; scientific analysis of nucleic acids, in particular for detection purposes; scientific and technological services, namely, scientific research, analysis and testing in the field of DNA for the treatment of nucleic acids and proteins, in particular separation, purification, isolation, labeling and amplification of the aforesaid molecules; development of software, in particular development of software for data analysis, for the analysis of bioinformatic data, sequence data and fragmented sequence information, and development of software for pcr analysis and next generation sequencing; scientific analysis of bioinformatic data, sequence data and fragmented sequence information, especially in the context of next generation sequencing
Case File Event Statements
  • 11/4/2023 - a year ago
    30 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 7/3/2023 - a year ago
    29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 6/9/2023 - a year ago
    28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/9/2023 - a year ago
    27 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/7/2023 - a year ago
    26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/7/2023 - a year ago
    25 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 3/7/2023 - a year ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/21/2022 - 2 years ago
    23 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/20/2022 - 2 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/20/2022 - 2 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/30/2022 - 2 years ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/30/2022 - 2 years ago
    19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 11/30/2022 - 2 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/14/2022 - 2 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/10/2022 - 2 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/10/2022 - 2 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/10/2022 - 2 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/10/2022 - 2 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/13/2022 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/12/2022 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/12/2022 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/10/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/16/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/16/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/7/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/6/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/1/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/22/2021 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/18/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/16/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR